{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:37:22Z","timestamp":1777934242829,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>Bleomycin is a glycopeptide used as a chemotherapeutic agent for lymphomas, germ cell tumors, and pleurodesis of malignant pleural effusions. The pulmonary toxicity of bleomycin is well known while the cutaneous side effects are uncommon and varies from generalized hyperpigmentation, sclerodermoid changes, erythema multiformae, and gangrene to flagellate dermatosis. Here we report a characteristic but rare side effect of flagellate erythema, which developed secondary to bleomycin in a 27-year old woman with Hodgkin\u2019s lymphoma after two cycles of treatment with adriamycin, bleomycin, vinblastine, dacarbazine regimen. The rash subsided after discontinuation of bleomycin and treatment with steroids.<\/jats:p>","DOI":"10.1177\/1078155215580468","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T22:12:40Z","timestamp":1428531160000},"page":"556-560","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Bleomycin-induced flagellate erythema in a patient with Hodgkin\u2019s lymphoma \u2013 A case report and review of literature"],"prefix":"10.1177","volume":"22","author":[{"given":"A","family":"Vennepureddy","sequence":"first","affiliation":[{"name":"Department of Medicine, Staten Island University Hospital, Staten Island, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MN","family":"Siddique","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Staten Island University Hospital, Staten Island, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Odaimi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Staten Island University Hospital, Staten Island, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Terjanian","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Staten Island University Hospital, Staten Island, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"bibr1-1078155215580468","first-page":"1079","volume":"5","author":"Umezawa H","year":"1965","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"bibr2-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1547"},{"key":"bibr3-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.7691"},{"key":"bibr4-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/480608"},{"key":"bibr5-1078155215580468","doi-asserted-by":"publisher","DOI":"10.2165\/11537080-000000000-00000"},{"key":"bibr6-1078155215580468","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.119358"},{"key":"bibr7-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.10.3064"},{"key":"bibr8-1078155215580468","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2010.306"},{"key":"bibr9-1078155215580468","first-page":"106","volume":"180","author":"Cortina P","year":"1990","journal-title":"With histopathological findings suggestive of inflammatory oncotaxis. Dermatologica"},{"key":"bibr10-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1991.tb00352.x"},{"key":"bibr11-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)70190-9"},{"key":"bibr12-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.337"},{"key":"bibr13-1078155215580468","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5070\/D31KK948KN","volume":"14","author":"Manoj J","year":"2008","journal-title":"Dermatol Online J"},{"key":"bibr14-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07238.x"},{"key":"bibr15-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962012000300017"},{"key":"bibr16-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.4457"},{"key":"bibr17-1078155215580468","first-page":"692","volume":"26","author":"Nousari H","year":"1999","journal-title":"J Rheumatol"},{"key":"bibr18-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1996.tb00151.x"},{"key":"bibr19-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02633.x"},{"key":"bibr20-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1177\/1078155208096111"},{"issue":"11","key":"bibr21-1078155215580468","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D36QJ3649F","volume":"18","author":"Mahmoud BH","year":"2012","journal-title":"Dermatol Online J"},{"key":"bibr22-1078155215580468","first-page":"2011","volume":"62","author":"Sikic BI","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"bibr23-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.110"},{"key":"bibr24-1078155215580468","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-6-823"},{"key":"bibr25-1078155215580468","first-page":"419","volume":"65","author":"Cooper KR","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"bibr26-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.99.010"},{"key":"bibr27-1078155215580468","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7243"},{"key":"bibr28-1078155215580468","author":"Behringer K","year":"2014","journal-title":"Lancet"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155215580468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155215580468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155215580468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:16:12Z","timestamp":1777688172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155215580468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1177\/1078155215580468"],"URL":"https:\/\/doi.org\/10.1177\/1078155215580468","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}